Clark Wealth Partners’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.66K Buy
20
+3
+18% +$693 ﹤0.01% 417
2026
Q2
$3.6K Hold
17
– – ﹤0.01% 356
2026
Q1
$3.33K Buy
17
+9
+113% +$1.75K ﹤0.01% 398
2025
Q4
$1.39K Hold
8
– – ﹤0.01% 460
2025
Q3
$1.39K Buy
8
+2
+33% +$355 ﹤0.01% 460
2025
Q2
$1.08K Hold
6
– – ﹤0.01% 427
2025
Q1
$1.02K Buy
+6
New +$986 ﹤0.01% 437

Other funds holding DGX

Clark Wealth Partners's DGX Position: Q3 2026 in Review

Clark Wealth Partners increased its Quest Diagnostics (DGX) stake by 18% in Q3 2026, buying an estimated $693 and bringing the position to 20 shares worth $4.66K. The position accounts for ﹤0.01% of the portfolio, ranked #417.

Clark Wealth Partners first reported a position in DGX in Q1 2025 and has held it in 7 quarters since. 1,007 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Clark Wealth Partners held 20 shares of Quest Diagnostics worth $4.66K as of Q3 2026.
  • Clark Wealth Partners bought 3 Quest Diagnostics shares in Q3 2026, an estimated $693.
  • Quest Diagnostics made up ﹤0.01% of Clark Wealth Partners's portfolio in Q3 2026, its #417 holding.
  • Clark Wealth Partners first reported a position in Quest Diagnostics in Q1 2025 and has held it in 7 quarters since.
  • 1,007 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Clark Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.